What is an infused kitchen?

The term “infused kitchen” describes a cuisine in which cannabis is not eaten as a separate element, but is anchored as an ingredient in the preparation – invisible in the oil, in the butter, in the honey. The result: a consistent experience, no unexpected surprises.

The advantages over other forms of consumption:

• Precise dosing possible (if the infusion is carefully measured)
• Gentler on the airways
• Longer lasting effect due to digestion
• Versatile – sweet and savory, hot and cold

The most important infusion bases: Butter, oil, honey, milk/cream and alcohol (for tincture). The right base is chosen depending on the dish.

Decarboxylation: the step that decides everything

Before cannabis can be infused into anything, decarboxylation must take place. Without this step, everything contains only THCA – ineffective. The principle:

1. Preheat the oven to 105-115 °C
2. Finely chop the cannabis (do not pulverize), spread on baking paper
3. Bake for 30-45 minutes – the color changes from light green to golden brown
4. Allow to cool, then infuse

This step applies to every infusion: butter, oil, honey, milk – always decarboxylate first.

Cannabis butter – the mother of all infusions

Cannabis butter is the most commonly used infused base – it goes equally well with desserts, brownies, cookies, toast and savory dishes. It is made from butter and decarboxylated cannabis, at low heat for several hours.

Basic recipe (250 g butter):

• 250 g butter
• 250 ml water
• 5-10 g decarboxylated cannabis
• Pot, fine sieve or cheesecloth

Melt butter and water, stir in cannabis, simmer for 2-3 hours at 70 °C (never allow to bubble). Filter through a sieve and leave to set in the fridge. The water separates and is poured off. What remains: intensely green, effective cannabutter.

Detailed recipe: Classic cannabutter – ZenCannaKitchen

Cannabis oil: versatile, strong, long-lasting

Cannabis olive oil has a slightly lighter taste than butter and is ideal for anyone who doesn’t want to use a dairy product. Particularly practical: it keeps for up to 3 months in the fridge and can be drizzled over ready-made dishes – i.e. without heat.

The principle is identical to cannabutter, only without water: heat olive oil at 70 °C, stir in cannabis, leave to infuse for 2 hours, filter. The video by ZenCannaKitchen explains the process very clearly:

Recipe: Cannabis olive oil – ZenCannaKitchen

Tip: Coconut oil works just as well and is ideal for vegan baking. You can also find the cannabis coconut oil recipe on ZenCannaKitchen.

Cannabis honey (cannahoney) – for tea, desserts and more

Cannahoney is an elegant infusion product: sweet, aromatic, versatile. It is perfect for cannabis tea, as a topping on pancakes, in dressings or pure on bread.

Basic recipe:

• 250 g raw honey
• 5 g decarboxylated cannabis

Heat the honey in a water bath to 70 °C, stir in the cannabis and simmer gently for 2 hours. Important: Never heat honey above 80 °C – it then loses its valuable enzymes and the THC potency drops. Filter and pour into jars.

Recipe: Cannabis honey – ZenCannaKitchen

Infused drinks: Cannabis tea and milkshake

Cannabis drinks are a category of their own. Important to know: THC hardly dissolves in pure water – drinks always need a fat base.

Cannabis tea: Tea alone therefore only works with an additive – either a sip of milk, a spoonful of cannabutter or a teaspoon of coconut oil. Only then is the THC from the leaves (or stems) effectively absorbed. The recipe: Boil water, infuse cannabis leaves for 10 minutes, mix with cannabutter. Recipe: Cannabis tea – ZenCannaKitchen

Cannabis milkshake: The fat base is already present here. Cannabis milk (whole milk boiled with cannabutter or cannabis oil for 30 minutes) is mixed with fruit, ice and spices. Ideal for warm days. Recipe: Cannabis milkshake – ZenCannaKitchen

Dosage in the infused kitchen

The central principle: no more than 5-10 mg THC per serving for beginners, 10-20 mg for experienced users. Because the effect only sets in after 30-90 minutes, patience is required – and a consistent no to re-dosing within this time frame.

If you want to find out more about the effects of cannabis: Cannabis for social anxiety and Cannabis for back pain provide a good overview of current studies. All current cannabis events in Germany are listed in the article Cannabis Events 2026.

Back pain: the most common pain problem in Germany

Chronic back pain permanently affects 15-17% of adults in Germany. It is the most common cause of incapacity for work and one of the most expensive illnesses in the healthcare system. Back pain is pharmacologically complex: nociceptive pain (tissue damage), neuropathic pain (nerve root compression), myofascial pain (muscle tension) and centralized pain (chronification) often overlap.

Cannabis intervenes via several mechanisms simultaneously – which makes it interesting for this complex pain pattern.

Pain mechanisms in back pain and ECS targets

Studies: Cannabis and back pain

Aviram & Samuelly-Leichtag 2017 (J Pain Res): Retrospective study, n=206, chronic pain patients using medical cannabis. 70% reported strong or very strong pain reduction. Back pain was the most common indication.

Ware et al. 2010 (CMAJ): RCT, n=21, neuropathic pain (not only back). Nabilone (synthetic THC) significantly better than placebo for pain intensity and sleep. Shows THC analgesia for neuropathic component.

Beaulieu et al. 2006 (J Rheumatol): Fibromyalgia and back pain often overlap. Nabilone better than amitriptyline for fibromyalgia pain and sleep. Indirectly relevant for chronic back pain with central sensitization.

Overview RCTs 2022 (Cochrane analysis): 16 RCTs on cannabis for chronic pain. Moderate evidence for pain reduction. Back pain-specific subgroup shows consistent, albeit moderate analgesia.

Opioid-saving effect for back pain

Many chronic back pain patients receive opioids – with considerable long-term risks (dependence, tolerance, constipation). Cannabis as an opioid adjuvant:

Reiman et al. 2017 (Cannabis Cannabinoid Res): Survey, n=2897 cannabis dispensary patients. 97% of patients who had substituted opioids preferred cannabis. 81% reported that cannabis alone was more effective than cannabis + opioid.

Practical recommendation: cannabis for back pain

Acute pain breakthrough: THC 5-10 mg vaporizer (immediate effect) or sublingual

Continuous pain: CBD 100-200 mg daily + THC 2.5-5 mg in the evening (sleep + muscle relaxation)

Topical (local tension): CBD cream/gel directly on pain point – CB2 in muscle and fascia, no systemic effect

Neuropathic component (sciatica): CBD 150-300 mg + beta-caryophyllene-rich terpenes (CB2 agonist)

FAQ: Cannabis for back pain

Summary

Cannabis addresses all four types of pain in chronic back pain: nociceptive (COX-2), neuropathic (TRPV1/CB1), myofascial (muscle relaxation), centralized (supraspinal modulation). Study data: 70 % pain reduction in survey, moderate analgesia in Cochrane analysis. Opioid saving effect clinically significant. Symptomatically effective for intervertebral disc problems, no substitute for causal therapy. Cannabis in neuropathy for the neuropathic component; cannabis in fibromyalgia for centralized pain.

Social anxiety disorder and the ECS

Social anxiety disorder (SAD) is one of the most common anxiety disorders with a lifetime prevalence of 12%. It is characterized by intense anxiety in social situations, fear of negative evaluation and often with avoidance behavior. The ECS modulates via CB1 in the amygdala and prefrontal cortex – precisely the areas of the brain that are over-activated in SAD.

CBD for social anxiety: study overview

Social anxiety is the best clinically studied area of application for CBD in psychiatry:

Bergamaschi et al. 2011 (Neuropsychopharmacol): RCT, n=24, patients with SAD. CBD 600 mg vs. placebo before simulated public speaking (Public Speaking Test – SPST). CBD significantly reduced anxiety, cognitive impairment and discomfort when speaking vs. placebo. Physiological: normalized heart rate increase and blood pressure response.

De Aquino et al. 2020 (Neuropsychopharmacol): Extended SPST design, CBD 300 mg. Confirmed anxiolytic effect; determined U-shaped dose-response curve: 300 mg optimal, 150 mg and 600 mg less effective.

Linares et al. 2019 (Front Pharmacol): Healthy volunteers, sleep + anxiety under stress. CBD 300 mg showed significant anxiolytic effect vs. placebo.

THC for social anxiety: the paradox

While CBD consistently reduces social anxiety, THC is problematic for SAD:
– THC increases anxiety and paranoia in medium to high doses
– Social situations are subjectively perceived as more threatening
– Cannabis users with SAD have a higher risk of panic attacks in groups

Recommendation for SAD: CBD isolate or broad spectrum without THC. Full-spectrum products with THC can worsen SAD symptoms.

Mechanisms of CBD in social anxiety

5-HT1A agonism: CBD activates serotonin 5-HT1A receptors – same mechanism as buspirone (anxiolytic drug). In the hippocampus and dorsal raphe nucleus relevant for social anxiety.

Amygdala modulation: CBD reduces amygdala activation in response to anxiety-inducing stimuli (fMRI study Bhattacharyya et al. 2012). Amygdala hyperactivation is a core finding in SAD.

Hippocampal neurogenesis: Chronic CBD promotes adult neurogenesis in the hippocampus – similar to SSRIs. Long-term anxiolysis through neuroplastic effect.

Practical application: CBD for social anxiety

Situational intake (before social situations):
– CBD 300 mg sublingual, 60-90 minutes beforehand
– Ideal for: Presentations, dating, social events, public speaking

Daily continuous therapy:
– CBD 150-300 mg daily as adjuvant therapy to psychotherapy
– No substitute for CBT (cognitive behavioral therapy) – the gold standard treatment for SAD

FAQ: Cannabis for social anxiety

Summary

CBD for social anxiety disorder is one of the best documented cannabis indications: two RCTs (Bergamaschi 2011, De Aquino 2020) show significant anxiolysis in SAD patients. Optimal dose: 300 mg CBD (U-curve). Mechanism: 5-HT1A agonism + amygdala modulation. THC contraindicated in SAD – exacerbates paranoia. CBD isolate or broad spectrum without THC. Cannabis for anxiety disorder for generalized anxiety; CBD dosing guide for anxiety dosing.

Crohn’s disease and the endocannabinoid system

Crohn’s disease is a chronic inflammatory bowel disease (IBD) that can affect any part of the digestive tract and is characterized by relapses of varying intensity. The endocannabinoid system is deeply integrated into intestinal homeostasis: CB1 and CB2 are found on intestinal epithelium, intestinal immune cells, enteric neurons and intestinal smooth muscle.

ECS and gut physiology: where cannabis comes in

Key studies: Cannabis and Crohn’s disease

Naftali et al. 2013 (Clin Gastroenterol Hepatol): First prospective RCT on cannabis in Crohn’s disease. n=21, cannabis vs. placebo (tobacco-placebo). Cannabis group (115 mg THC/day via joints): 45 % full remission vs. 10 % placebo. Statistically significant. But: small number of cases, blinding problematic due to obvious effect.

Naftali et al. 2017 (Pharmacology): Follow-up with CBD oil specifically. CBD alone without THC: no significant improvement in disease activity (CDAI score). Conclusion: THC component more important for remission induction than CBD.

Irving et al. 2018 (J Crohns Colitis): RCT, n=60, cannabidiol in ulcerative colitis. CBD showed no significant superiority over placebo on clinical remission. But: quality of life and some inflammatory parameters improved.

Conclusion: THC in active Crohn’s disease shows clinical remission potential. CBD alone is not sufficient for remission induction, but can improve quality of life and pain.

Practical application: cannabis for Crohn’s disease

Acute attack (pain relief):
– THC 5-10 mg via vaporizer (immediate onset of action, intestinal motility ↓, analgesia)
– CBD 50-100 mg sublingual (anti-inflammatory, TRPV1 desensitization)

Maintenance of remission (daily intake):
– CBD 50-100 mg daily (anti-inflammatory, intestinal permeability)
– Full spectrum preferred for entourage effect (Naftali 2013: THC full spectrum more effective than CBD alone)

Sleep disorders in Crohn’s disease:
– CBD 150 mg + THC 5 mg in the evening

Augmentation problem with Crohn’s immunosuppressants

Crohn’s patients often receive immunosuppressants (azathioprine, infliximab). CBD inhibits CYP3A4 and CYP2D6 – relevant enzymes for the metabolism of these drugs. In case of combination: medical consultation mandatory due to interaction potential.

FAQ: Cannabis for Crohn’s disease

Summary

ECS is deeply integrated into intestinal physiology: CB1 on motility and permeability, CB2 on intestinal immune response. Naftali 2013 shows 45% Crohn’s remission with THC cannabis. CBD alone weaker for remission induction, but valuable for pain and quality of life. Full spectrum preferred. Check drug interactions with immunosuppressant combination. Cannabis and immune system for CB2 mechanisms; cannabis in irritable bowel synd rome for related bowel diseases.

Restless legs syndrome and the endocannabinoid system

Restless legs syndrome (RLS) is a neurological disorder characterized by an agonizing urge to move the legs – especially at night. It affects 5-10% of the population. The underlying pathophysiology involves dopaminergic dysregulation in the basal ganglia and spinal pain processing – two systems where the ECS directly intervenes.

Neurobiological connection: RLS and ECS

Dopamine-ECS connection: CB1 receptors are located on dopaminergic neurons in the substantia nigra and striatum. Cannabis cannabinoids modulate dopamine release – relevant for RLS whose main treatment is dopaminergic drugs (pramipexole, ropinirole).

Spinal pain modulation: RLS symptoms are partly caused by spinal nociceptor overactivation. CBD desensitizes TRPV1 and inhibits COX-2 in the spinal cord – possibly relevant for the burning and tingling sensations.

Sleep: RLS leads to massive sleep disorders. Cannabis (CBD 150 mg + low THC) has a sleep-inducing effect – symptomatically helpful even if no causal effect.

Study situation: Cannabis for RLS

There are hardly any specific RCTs on cannabis and RLS:

Ghorayeb 2020 (Sleep Med): Case Series, n=6 patients with RLS who did not respond to conventional therapy. All 6 reported complete or substantial symptom remission with cannabis (inhalation or oral ingestion). Case series limitations, but relevant for a rare treatment-resistant disease.

Walther et al. 2021 (Mov Disord): Survey, n=428 RLS patients. 36% used cannabis. Of these, 70% reported an improvement in RLS symptoms. Sleep and sense of calm improved the most.

Mechanistic: Dopamine-modulating effects of THC at low doses could improve RLS via similar pathways as dopamine agonists. Not directly proven, but pharmacologically plausible.

What could help best with RLS

In the evening before going to sleep:
– CBD 100-150 mg sublingual (sleep + TRPV1 desensitization)
– THC 2.5-5 mg low (dopaminergic modulation; muscle relaxation)
– Full spectrum with high myrcene terpene content (sedative, muscle relaxant)

For augmentation (dopamine agonist side effect):
Augmentation is the most feared side effect of pramipexole/ropinirole – exacerbation of RLS symptoms by the drug itself. Cannabis as an adjuvant or alternative option for augmentation is clinically interesting.

Important: Cannabis may interact with dopamine agonists (CYP3A4 inhibition by CBD). Medical consultation for combination.

FAQ: Cannabis and restless legs

Summary

RLS and ECS are linked via dopaminergic modulation and spinal pain processing. Survey data (Walther 2021: 70% improvement) and case series data (Ghorayeb 2020: complete remission in 6 cases) are promising. Clinical RCTs are missing. Evening CBD 100-150 mg + low THC is the practical recommendation. No substitute for dopamine agonists, but useful adjuvant option. Cannabis for sleep disorders for the sleep component; cannabis for neuropathy for spinal pain modulation.

The endocannabinoid system in bone metabolism

Bones are living tissues that are constantly being remodeled – by osteoblasts (bone formation) and osteoclasts (bone resorption). The endocannabinoid system directly regulates this remodeling: CB1 and CB2 are expressed by both cell types, and endocannabinoids are important modulators of bone physiology.

CB2 receptors are the dominant cannabinoid receptor class in bone – which means that cannabinoids without a psychoactive CB1 effect (such as CBD, CBG, beta-caryophyllene) can act on bone.

CB1 and CB2 in bone: Different functions

Study situation: cannabinoids and bone density

Idris et al. 2005 (Nat Med): CB2 knockout mice developed age-related osteoporosis faster and more severely than wild-type mice. CB2 activation protects against osteoporotic bone loss. Conversely, CB2-selective agonists increased bone density in animal models.

Idris et al. 2009 (Bone): CB2 agonist JWH-133 prevented ovariectomy-induced osteoporosis in mice. Mechanism: Inhibition of osteoclastogenesis via RANKL suppression.

Ofek et al. 2006 (PNAS): Anandamide and CB2 activation inhibit osteoclastogenesis and promote osteoblast activity in vitro. CB2 could be a therapeutic target for osteoporosis.

Cannabis and fracture healing – Koren et al. 2019 (J Bone Miner Res): CBD significantly accelerated bone healing in rat fracture model. Bones in the CBD group had higher bending stiffness and better mineralization after 8 weeks.

Clinical implications: Osteoporosis and cannabis

Osteoporosis affects 6 million people in Germany – mainly postmenopausal women and older men. Paradoxically, THC could have a bone-degrading effect on osteoclasts through CB1 activation:

Muniyappa et al. 2013 (Bone): Survey study: Chronic cannabis users had lower bone density in some cohorts. But confounders (nicotine, alcohol, BMI) difficult to control.

Conclusion for practice: CBD (without THC): potentially bone-protective via CB2. THC with high chronic consumption: possible risk of osteoporosis through CB1 on osteoclasts. No clinical use of cannabis as osteoporosis therapy at present.

FAQ: Cannabis and bones

Summary

CB2 receptors in bone regulate osteoblasts and osteoclasts. CB2 activation has a bone-anabolic effect and inhibits resorption – strongly supported by preclinical evidence (Idris 2005, 2009). CBD promotes fracture healing in animal models (Koren 2019). Chronic THC associated with lower bone density in some studies. Clinical human studies are lacking for direct therapeutic use. CB2 immune system guide for further CB2 knowledge; cannabis in rheumatism for related joint diseases.

Cannabis and the male hormone system

Testosterone and male fertility are a relevant topic for cannabis users. The endocannabinoid system is directly integrated into the hypothalamic-pituitary-gonadal (HPG) axis, which regulates testosterone and sperm production. CB1 receptors are found in the hypothalamus, pituitary gland and testes.

Effects of THC on male hormones

Study situation: cannabis and testosterone

Kolodny et al. 1974 (NEJM): First large study. Daily cannabis users had significantly lower testosterone levels than non-users. Study with methodological weaknesses; but fundamentally important.

Gundersen et al. 2015 (Am J Epidemiol): n=1215 young Danish men. Weekly cannabis use associated with 28% lower sperm concentration vs. non-users. Daily use + other drug use: up to 52 % reduction.

Hall et al. 2021 (Human Reprod): No statistically significant association between cannabis use and sperm parameters in younger cohort. Conflicting data confirmed.

Current consensus (2024): Moderate, occasional cannabis use probably has minimal effect on fertility. Daily use, especially >10 mg THC/day, is associated with hormonal and sperm changes. Effects are reversible with abstinence.

CB1 on sperm: Direct effect

Sperm cells express CB1 receptors. Anandamide directly modulates the acrosome reaction (necessary for oocyte penetration) and sperm motility:
– Low anandamide levels: stimulating for motility
– High anandamide/THC levels: inhibitory for motility

THC competes with anandamide for CB1 on sperm – direct inhibition of sperm function has been proven.

What does this mean in practical terms for the desire to have children?

If you actively wish to have children:
– Abstinence from cannabis containing THC at least 3 months before the planned attempt to conceive
– Sperm maturation takes 74 days – all sperm produced today will only be ready for ejaculation in 74 days
– CBD: no relevant negative effects on fertility proven

FAQ: Cannabis and testosterone

Summary

THC has negative effects on testosterone (up to -30 %) and sperm parameters with daily use via CB1 in the HPG axis and directly on sperm. Gundersen 2015 shows -28 % sperm concentration with weekly use. All effects reversible after 4-8 weeks (hormones) or 3 months (sperm). If you want to have children: 3 months abstinence. CBD has no relevant negative fertility effects. Tolerance break for abstinence tips; CBD vs. THC for the fundamental difference.

Why cannabis quality is so important

Cannabis quality is not just a question of the active ingredient content. For medical patients, contamination with pesticides, mold spores, heavy metals or synthetic cannabinoids pose serious health risks. In Germany, medicinal cannabis flowers from pharmacies must meet strict GMP standards – recreational cannabis from non-regulated sources does not.

Important quality parameters in the laboratory

Medical cannabis in Germany: GMP standard

Pharmacy cannabis in Germany must be certified according to GMP (Good Manufacturing Practice):
– Federal Institute for Drugs and Medical Devices (BfArM) monitors
– Bedrocan, Bediol, state cultivation (BtMG license): all fully analyzed
– Certificate of Analysis (CoA) must be available for each batch

What should be on the CoA:
– THC/CBD mg/g (not only %)
– Terpene profile
– Pesticide release
– Mold spore count
– Heavy metal release

Recreational cannabis: how good is the quality really?

Cannabis from illegal sources has no quality control. Analysis projects such as SaferParty Zurich and drug-checking centers (Vienna, Frankfurt) regularly show this:
– 15-25% of samples contain pesticide residues above EU limits
– Common extenders: synthetic cannabinoids (NPS), lead, glass dust in hash
– THC content often does not match seller statements (±30-50 %)
– Mold due to improper storage: common in imported cannabis

Mold and immunocompromised people: critical risk

Aspergillus fumigatus – a common mold on cannabis – is largely harmless for healthy people. For immunocompromised people (cancer patients, HIV, transplant patients), an Aspergillus infection from inhaled cannabis can be life-threatening.

Study: Tashkin 2002 (Chest): Aspergillus spores detected on cannabis samples from Los Angeles. Recommendation: Immunocompromised persons should only smoke cannabis from GMP-certified sources and not smoke it (vaporizer at 170-185°C kills spores).

Drug checking: safety tests in Germany

Drug checking has been expanded since the legalization of cannabis. There are model projects in Frankfurt and Hamburg where users can have their cannabis tested anonymously:
– Rapid test: reagent strips for basic checks (NPS, heroin admixtures)
– Laboratory check: full analysis for cannabinoids, pesticides, heavy metals

FAQ: Cannabis quality and laboratory tests

Summary

Cannabis quality includes cannabinoid content, terpene profile, pesticide-free, mold-free and heavy metal control. Medical pharmacy cannabis in Germany is subject to GMP control with full CoA. Recreational cannabis without quality control regularly shows contamination in analyses. Mold on cannabis is a critical risk for immunocompromised people. Drug checking sites offer free anonymous testing. Consumption forms for safer inhalation; medical cannabis on prescription for GMP-safe cannabis.

What the CanG allows you to grow yourself

Since the Cannabis Act (CanG) came into force on April 1, 2024, adults aged 18 and over have been allowed to grow cannabis at home in Germany. This is a historic change – but with clear limits.

Home cultivation: what is allowed

Legal basis: CanG §§ at a glance

§ 9 CanG: Self-cultivation for adults: 3 plants, not publicly visible to minors.

§ 3 CanG: Possession up to 25 g in public, up to 50 g at home.

§ Section 5 CanG: Free transfer of up to 25 g between adults – only without consideration.

Important: Commercial cultivation, propagation for third parties, sale = still a criminal offense (§ 34 CanG).

Buying seeds: What is legal?

Cannabis seeds have always been legally available in Germany as collector’s items and for home cultivation – as long as they are not used for illegal trade. Dutch and Spanish seed banks are the most common sources of supply. Since CanG, the purchase for private home cultivation (3 plants) is legally uncritical.

What to look out for:
– Feminized seeds: Only female plants produce flowers (THC/CBD)
– Autoflowering: flowering according to time instead of light rhythm – easier for beginners
– THC content: For medical users often 15-20 % THC varieties; for relaxed recreational use 10-15 %

Growing basics: indoor vs. outdoor

Outdoor (balcony/garden):
– Seasonal (April-October in Germany)
– No electricity costs
– Yield of up to 100-500 g per plant possible
– Weather-dependent; risk of mold in damp autumns

Indoor (grow box):
– All year round; 2-3 harvests per year possible
– LED lighting: 200-400W for 3 plants; full-spectrum LED optimal
– Light rhythm: 18h light / 6h dark (vegetative) → 12h / 12h (flowering)
– Temperature: 20-28°C; humidity: vegetative 60-70 %, flowering 40-50 %
– CO₂: Ambient air sufficient with good air exchange

Harvesting and storage

Harvest time: Check trichomes under a magnifying glass – milky-white = peak THC; amber-colored = THC → CBN degradation begins.

Drying: 10-14 days at 18-22°C, 50-55 % humidity; hang upside down.

Curing: Glass jar, open briefly every day (burping), 2-4 weeks. Improves taste and effect considerably.

Storage: Dark, cool, airtight. No refrigerator (moisture/mold). Vacuuming optimal.

FAQ: Cannabis home cultivation according to CanG

Summary

Since CanG (April 2024), 3 plants are legal at home; 50 g possession at home, 25 g passed on free of charge. Buy seeds legally, visual protection for minors mandatory. No sale, no commercial cultivation. Indoor grow with LED: 2-3 harvests per year possible. Dry and cure harvest correctly for maximum preservation of active ingredients. Cannabis legal status Germany for full CanG details; decarboxylation for further processing of the harvest.

What is cannabis microdosing?

Microdosing means taking cannabis in such low doses that the therapeutic or mood-enhancing effects are noticeable, but there is no perceptible high. For THC, this is typically 1-5 mg per dose. The concept is particularly relevant for:
– Medical users who want to maintain everyday functionality
– People with low THC tolerance
– Anxiety patients for whom high THC doses trigger panic
– Creative work (slight opening of perception without functional impairment)

Biphasic THC effect: less is more

THC shows a classic biphasic dose-response curve – a basic principle of cannabinoid pharmacology:

Low dose (1-5 mg): Anxiolytic, mood enhancing, mildly focusing, analgesic without sedation

Medium dose (10-20 mg): Euphoria, relaxation, hunger, slight time distortion – classic recreational high

High dose (25-50 mg+): paranoia, anxiety, disorientation – especially in beginners or without tolerance

The paradox: if you want to take cannabis for anxiety, you have to dose low. Higher doses worsen anxiety in many cases.

Microdosing protocol according to experience level

CBD microdosing: why even too little is too little

CBD also shows a biphasic dose effect:
– Too low (<10 mg): Often no noticeable effect
– Moderate (30-100 mg): Anxiolytic, anti-inflammatory, sleep-inducing
– High (150-300 mg): Sleep-inducing, antiepileptic (clinically relevant)

For anxiety: at least 25-50 mg CBD daily for consistent effects. Many users take too little (10 mg softgel) and report no effect – this is a dosing issue.

Practical microdosing methods

Vaporizer: Most precise method for THC. Small puff = ~1-2 mg THC, depending on strain. Effect noticeable in seconds, quick adjustment possible.

Sublingual oil: pipette with 1/4 drop of THC oil or precise CBD oil dosage. Good control.

Microdosing capsules: 2.5 mg THC capsules are medically available; simplest form for precise daily dosing.

Tincture: dropwise control; alcohol-based = fastest oral absorption.

FAQ: Cannabis microdosing

Summary

Microdosing utilizes the biphasic THC dose-response: 1-5 mg THC produces therapeutic effects without intoxication. CBD microdosing starts at 25-50 mg daily for measurable anxiolytic effects. Methods: vaporizer (most precise), sublingual oil, capsules. For daily use: cycling (5 days on, 2 days off) for tolerance avoidance. Tolerance break guide; CBD dosage guide for all indications.